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Abstract 
Objective: To design and assess an innovative session for pharmacy students that addresses the role of pharmaceuticals with climate 
change and sustainability. 
Innovation: One hundred and sixteen third-year students at the University of California, San Francisco School of Pharmacy participated 
during their required Health Policy course. This 3-hour session included guided pre-course activities, an interactive lecture, a panel of 
healthcare professionals discussing complex decision-making and small group case-based learning. Curricular assessment was 
conducted through pre-/post-test measures of knowledge acquisition, student evaluations, and course projects. 
Critical Analysis: One hundred and two students (response rate 88%) completed the pre-test and 115 students (response rate 99%) 
completed the post-test assessment. We identified a significant increase in the proportion of correct answers on post-test questions 
addressing drug disposal legislation (75% pre-test vs 91% post-test, p=0.002) and the predicted effects of climate change on health 
(55% pre-test vs 90% post-test, p < 0.001). The session was also well received; average student evaluation scores were above 4 in all 
areas of course evaluation (where 5=ideal). In addition, 17% of student groups (relative to 0% in 2015) proposed a sustainability-related 
policy as their final coursework project. 
Next Steps: The development and implementation of this brief session resulted in knowledge gain and favorable student response. This 
project is feasible for other Schools of Pharmacy to adapt and implement. 
Keywords:  Environmental impact, Sustainability, Pharmacy, Education, Pharmaceuticals 
 
Disclosures: None 
 
 
Introduction 
Climate change is described as ‘the greatest global health 
opportunity of the 21st century’. As a result of climate change, 
a greater incidence of vector-borne diseases, heat stress, and 
malnutrition is anticipated.1 Additionally, certain co-morbid 
populations will likely be disproportionally affected by 
extreme environmental conditions.2 For example, a patient 
with asthma may experience more frequent disease 
exacerbations due to poor air quality.   
 
Increased disease burden will be met with greater 
pharmaceutical utilization and demand. Pharmaceuticals 
impact the environment from drug development to disposal. 
In 2007, the U.S. healthcare system contributed an estimated 
7% of total carbon dioxide emissions, of which 39% was 
attributed to hospitals and 14% to pharmaceutical 
companies.3 In addition to the carbon footprint of 
pharmaceutical companies, inappropriate pharmaceutical 
disposal leads to contamination of water and bioaccumulation 
in wildlife. Historically, waste treatment was expected to  
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degrade any active pharmaceutical compounds to an 
acceptable risk level. More recently, however, reports of 
feminized fish have been attributed to water contaminated 
with estrogen-containing contraceptives.4 Increased 
pharmaceutical consumption will only amplify the 
environmental consequences of the pharmaceutical lifecycle.  
It is imperative for healthcare trainees and professionals 
worldwide to be aware of these issues and to advocate for 
‘greener’ pharmaceutical production and disposal. Some 
countries have responded to this need by introducing formal 
training for students studying medicine and nursing.5,6 
Recognizing the scope of this issue within the U.S., the CDC has 
emphasized training of “…public health staff to respond to the 
health threats posed by climate change” as a priority health 
action.7 Like physicians and nurses, pharmacists have a vital 
role to play in climate-related prevention, education, and 
policy. Within pharmacy education, the 2013 Center for the 
Advancement of Pharmacy Education (CAPE) Educational 
Outcomes support teaching environmental health topics as 
part of, “evaluating personal, social, economic, and 
environmental conditions to maximize health and wellness”.8 
However, pharmacy curricula that address these concepts 
have not been identified within the literature. 
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Statement of Innovation 
Recognizing the crucial need to include these topics within 
pharmacy education, we designed, implemented, and 
evaluated a three-hour session at The University of California, 
San Francisco (UCSF) School of Pharmacy. Our educational 
materials focused on the relationships between climate 
change, sustainability, and pharmaceuticals. We predicted this 
session would increase student knowledge in these areas.  
 
The Innovation 
The UCSF School of Pharmacy offers a required health policy 
course for third-year pharmacy students. Each session meets 
for three hours per week for a total of 10 weeks between 
September and December each year. The decision to 
incorporate this session within the existing health policy 
course was based on a 2015 drug disposal policy in San 
Francisco that mandated citywide pharmaceutical “take back” 
and the creation of a campus-wide sustainability initiative in 
2008. Our goals were to: (1) introduce and expand student 
knowledge of the relationships between climate change, 
sustainability, and healthcare and (2) inspire pharmacist 
involvement through health policy awareness and action. We 
emphasized a stakeholder-approach when analyzing current 
practices and identifying opportunities for sustainable change.  
 
One week prior to this session, students were invited to take a 
multiple-choice pre-test assessment of knowledge via an 
anonymous QualtricsTM (Qualtrics, Provo, UT) online link. 
These questions addressed four key concepts related to the 
session goals: (1) the impact of climate change on health, (2) 
options for controlled substance disposal, (3) local drug 
disposal policy, and (4) available environmental health web 
resources.  
 
Just prior to the session, students were asked to work in small 
groups to complete pre-course readings and corresponding 
questions. The goal of this work was to introduce the direct 
effects of pharmaceuticals on the environment (Appendix 1). 
Each group responded to the questions in an online forum 
monitored by the session instructor. Selected student 
responses were later incorporated within the large group 
didactic session.  
 
We employed a variety of active teaching methods during the 
class (Figure 1). Students first engaged in a large group 
discussion that reinforced and expanded upon concepts 
addressed in the pre-coursework. We encouraged 
participation through an anonymous audience response 
system, Poll Everywhere® (PollEverywhere, San Francisco, CA). 
Later in the session, students worked in small groups to 
examine the environmental impact of pharmaceuticals from 
drug development to disposal (Figure 2). To provide clinical 
context to our discussion, a patient case was introduced. 
Students were instructed to evaluate the environmental 
impact of amoxicillin prescribed for a pediatric case of possible 
otitis media. During this exercise, students applied their 
knowledge of pharmaceutical chemistry, health system supply 
chain management, antimicrobial stewardship, dispensing 
preferences, and medication disposal options.  
 
Following this conversation, another patient case involving a 
nebulizer to inhaler pharmaceutical substitution program was 
presented. This case was adapted from an actual policy 
adopted at UCSF Medical Center in 2013. The policy required 
all eligible inpatients receiving nebulized bronchodilators to be 
transitioned to inhalers within 24 hours of initial nebulized 
administration. This policy was chosen to highlight the 
unintended environmental impact of increased inhaler waste. 
 
After the students reflected upon the case, a panel of 
professionals in medicine, pharmacy, respiratory therapy, and 
environmental sustainability were invited to discuss the 
nebulizer-to-inhaler policy (Appendix 1). The panelists 
modeled a collaborative approach to balancing resource 
utilization, operations, and costs with quality care. The patient 
perspective, represented by an actor, generated a dialogue 
around the role of patient beliefs within health system policy 
development. The panel was videotaped for use in                       
future sessions and for external dissemination 
(https://vimeo.com/230639355).  At the conclusion of the 
panel, students re-grouped to consider whether they would 
have adopted this policy given the environmental implications 
alongside each stakeholder perspective. 
 
Students were then invited to take the same 4-question 
multiple-choice assessment via an anonymous QualtricsTM 
(Qualtrics, Provo, UT) online link. Assessment was conducted 
through pre-/post-test measures of knowledge acquisition, 
student evaluations, and course projects. Test responses were 
exported and analyzed within Microsoft Excel v. 15.35 for 
Mac (Redmond, Washington). Statistical significance was 
defined a priori when p < 0.05. Since participant responses 
were anonymous and unpaired, intergroup pre-/post-test 
responses were analyzed using Chi-squared test. This pilot 
study was approved through exemption by the UCSF 
Institutional Review Board (IRB#16-20893). 
 
Critical Analysis 
One hundred and sixteen third-year pharmacy students 
attended this course in 2016. One hundred and two students 
(response rate 88%) completed the pre-test and 115 students 
(response rate 99%) completed the post-test. We identified a 
significant increase in the proportion of correct answers on 
post-test questions addressing drug disposal legislation (75% 
pre-test vs 91% post-test, p= 0.002) and the predicted effects 
of climate change on health (55% pre-test vs 90% post-test, 
p<0.001). Questions addressing options for controlled drug 
disposal (68% pre-test vs 74% post-test, p=0.31) and 
informational resources (43% pre-test vs 50% post-test, 
p=0.28) showed a trend towards increased knowledge, but 
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these results were not statistically significant. We suggest a 
few reasons for these results. First, there are competing 
interests between environmental priorities and diversion of 
controlled substances. The DEA and FDA support drug take 
back programs, but also the disposal of controlled substances 
in the trash or toilet to minimize diversion. Therefore, student 
responses varied between these disposal methods. Regarding 
the informational resource question, a list of references was 
provided at the close of the session, but it was not emphasized 
within the learning objectives. In the future, it would be 
beneficial to invite a deeper conversation about controlled 
substance disposal and to spend more time emphasizing 
resources students and patients can consult for additional 
information.   
 
The final course assignment required student groups to 
present a health-related policy inspired by one of the course 
sessions. Five of 30 student groups (17%), relative to 0% in 
2015, proposed a sustainability-related policy for this 
assignment. The primary themes of these policies included: 
drug disposal information on pharmaceutical package inserts, 
reduction of inhaler hazardous waste, and drug take-back 
programs.  
 
At the conclusion of the term, 31% of students were randomly 
assigned to complete teaching evaluations by the UCSF Office 
of Student and Curricular Affairs. The results of these 
evaluations suggest the session was well-received. Average 
student evaluation scores were above 4 (Likert Scale, where 
1=strongly disagree and 5=strongly agree) in all areas of course 
evaluation. The evaluation themes and corresponding student 
evaluation scores (mean ± SD) were as follows: learning 
session was well-organized (4.17 ± 0.74) and participation was 
encouraged (4.11 ± 0.75). Student comments also positively 
reflected the overall value of the course. One student 
remarked, “I really appreciate that this topic gets brought up 
because we often don’t think about what happens to unused 
medications.” Another student commented, “They [session 
materials] were easy to follow and gave students insight about 
the importance of sustainability with pharmacy practice”. 
 
Discussion 
The environmental impact of pharmaceuticals is well 
established, yet curricula addressing this topic have not been 
identified in the literature. Before the implementation of this 
session, only half of UCSF pharmacy students were aware of 
the effects of climate change on health. However, a recent 
survey of 1,275 American adults revealed that 64% of 
respondents thought global warming has negative health 
implications and, amongst various sources, primary care 
doctors were designated as the most trusted source of 
information, before the Environmental Protection Agency, 
World Health Organization, and Centers for Disease Control 
and Prevention.9 This knowledge disconnect and public trust in 
healthcare professionals emphasizes the need to incorporate 
these topics within health professions education. The 
International Pharmaceutical Federation has taken a 
professional stance on this topic by issuing a policy statement 
for implementation of environmentally sustainable pharmacy 
practices and education.10 While this is a progressive policy, 
implementation is lagging within the U.S. 
 
Pharmacists have significant potential to mitigate the 
environmental risks of pharmaceuticals. In Sweden, a drug 
database (www.fass.se) has been developed to classify the 
environmental risk of medications.11 The data are provided 
voluntarily by pharmaceutical companies and then reviewed 
by the Swedish Environmental Research Institute, an 
independent organization. Each drug is evaluated on 
environmental hazard, persistence, and bioaccumulation risk. 
For example, data from AstraZeneca reveal that amoxicillin 
causes moderate environmental risk, is potentially persistent, 
and has low potential for bioaccumulation.12 This information 
is publicly available and could be incorporated into the 
therapeutic decision-making process. In fact, we used this 
database during our otitis media case to discuss the value of 
such a tool in the prescribing process. All other things being 
equal, selecting a drug with reduced environmental impact is 
preferred. Within the United States, the National 
Environmental Policy Act of 1969 requires the FDA to evaluate 
the environmental impact of drugs and biologics. 
Pharmaceutical companies must submit an environmental 
assessment or claim an exclusion when submitting 
applications for new drugs, abbreviated new drugs, biologic 
licenses, or investigational new drugs.13 With this information, 
the possibility of creating a similar database within the United 
States is feasible.  
 
However, until such a tool is available and accepted within the 
U.S., pharmacists can emphasize proper pharmaceutical 
disposal through education of healthcare providers and 
patients. San Francisco created a Safe Drug Disposal 
Stewardship Ordinance in 2015, which requires 
pharmaceutical companies to facilitate safe drug disposal 
throughout the city.14 Volunteer collectors include law 
enforcement, local pharmacies, and mail-back programs. As of 
June 2017, the California Board of Pharmacy has finalized the 
regulation of pharmacies and healthcare settings with onsite 
pharmacies that provide pharmaceutical take-back services.15 
Promoting awareness of these services to pharmacists, 
prescribers, and patients is an important step towards 
reducing the environmental impact of pharmaceuticals.  
 
Next Steps 
Pharmacy curricula addressing the interaction between 
climate change and pharmaceuticals are pertinent, yet lacking 
within the United States.2 The development and 
implementation of this brief session resulted in knowledge 
enhancement and favorable student response.  
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We presented our session internally to the UCSF Carbon 
Neutrality Initiative Faculty group in December 2016 
(http://sustainability.ucsf.edu/3.656) and in modified format 
to the pharmacists at the UCSF Medical Center in December 
2016.  We also shared this internationally at the Monash 
University Pharmacy Education Symposium in June 2017 
(https://www.monash.edu/pharm/about/events/education-
symposium), where we identified potential international 
collaborators.  
 
This session will be used again in the 2017 Health Policy course 
at UCSF. Looking forward, we hope to collaborate with other 
U.S. pharmacy programs to strengthen and extend this work. 
To facilitate the adaptation of this session by other schools, our 
teaching materials are available for use through Creative 
Commons licensing at pharmacademy.org. An abbreviated 
version of these materials is available to preview in        
Appendix 1. 
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Figure 1: Summary of Session Components 
 
 
 
 
 
Figure 2: Sustainable Pharmaceutical Life Cycle 
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Appendix 1: Preview of course materials 
 
Full materials are on pharmacademy.org. 
 
Pre-Coursework:  
 
Review the following links/articles and answer group questions: 
o “Drugs in the Water”: https://www.health.harvard.edu/newsletter_article/drugs-in-the-water 
o Lubick N. Drugs in the environment: do pharmaceutical take-back programs make a difference? Environ Health 
Perspect.2010;118(5):A210-4. 
o Explore the hospital on Tox Town: https://www.toxtown.nlm.nih.gov/scenes/city/scene.php 
 
Selected Group Discussion Questions  
1. Based on your reading of ‘Drugs in the Environment’ and ‘Drugs in the Water’, describe the pros and cons of the three 
pharmaceutical disposal methods (take-back programs, flushing, and trash disposal). Then describe how you would counsel 
a patient to dispose of their pharmaceuticals.  
2. Consider the ways in which hospital or community pharmacies create unnecessary waste and develop an actionable plan to 
reduce the pharmacy’s environmental impact.   
3. Based on your readings, brainstorm potential legislation that could be implemented to address the environmental impact of 
pharmaceuticals.  
 
 
In class: Complex Decision-making Panel (https://vimeo.com/230639355)   
 
Stakeholder Panelist Perspective 
Administration Catherine Lau, MD Value 
Environment Gail Lee, REHS, MSEM, HEM Sustainability 
Clinician – pharmacy Fanny Li, PharmD, BCPS, BCCCP Formulary  
Clinician – respiratory therapy Brian Daniel, RCP, RRT Workflow 
Patient Evans Whitaker, MD, MLIS Convenience 
 
Panelist Remarks:  
1. From your professional perspective, what would be the benefit of implementing the ‘Nebs No More After 24’ proposal?  
2. What are some considerations or concerns you have regarding this proposal specifically related to your role?  
3. Do changes in the political climate (within the health-system or within the wider world) influence this decision? If so, how?  
 
 
